Selected research
Industry Research
Pharmacovigilance Services and Solutions Industry Research Report 2026
Market perspective
The global Pharmacovigilance Services and Solutions market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmacovigilance Services and Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmacovigilance Services and Solutions market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmacovigilance Services and Solutions market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmacovigilance Services and Solutions include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmacovigilance Services and Solutions market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacovigilance Services and Solutions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacovigilance Services and Solutions Market by Company
Eurofins Scientific
Accenture
PPD
SGS
WuXi AppTec
Cognizant
ICON
IQVIA
Parexel
United BioSource
Vial
Wipro
PrimeVigilance
Aixial Group
TransPerfect
ProPharma
HCLTech
QbD Group
Quanticate
Qinecsa Solutions
Veristat
Veeda
Tigermed
Clarivate
Pharmacovigilance Services and Solutions Segment by Type
Writing and Submitting Documents and Reports
Security Database System Services and Data Management
Signal Detection and Evaluation
Training and Consulting
Other
Pharmacovigilance Services and Solutions Segment by Application
Preclinical
Clinical Phase
Post-launch
Pharmacovigilance Services and Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance Services and Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance Services and Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance Services and Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacovigilance Services and Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Pharmacovigilance Services and Solutions Revenue Market Share by Type (2021-2026)
Table 7. Global Pharmacovigilance Services and Solutions Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Pharmacovigilance Services and Solutions Revenue Market Share by Type (2027-2032)
Table 9. Global Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Pharmacovigilance Services and Solutions Revenue Market Share by Application (2021-2026)
Table 11. Global Pharmacovigilance Services and Solutions Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Pharmacovigilance Services and Solutions Revenue Market Share by Application (2027-2032)
Table 13. Global Pharmacovigilance Services and Solutions Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Pharmacovigilance Services and Solutions Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Pharmacovigilance Services and Solutions Market Share by Region (2021-2026)
Table 16. Global Pharmacovigilance Services and Solutions Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Pharmacovigilance Services and Solutions Market Share by Region (2027-2032)
Table 18. Pharmacovigilance Services and Solutions Industry Trends
Table 19. Pharmacovigilance Services and Solutions Industry Drivers
Table 20. Pharmacovigilance Services and Solutions Industry Opportunities and Challenges
Table 21. Pharmacovigilance Services and Solutions Market Restraints
Table 22. Global Top Pharmacovigilance Services and Solutions Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Pharmacovigilance Services and Solutions Revenue Market Share by Players (2021-2026)
Table 24. Global Pharmacovigilance Services and Solutions Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Pharmacovigilance Services and Solutions, Headquarters and Area Served
Table 26. Global Pharmacovigilance Services and Solutions Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pharmacovigilance Services and Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Pharmacovigilance Services and Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Pharmacovigilance Services and Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Pharmacovigilance Services and Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Pharmacovigilance Services and Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Pharmacovigilance Services and Solutions Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Pharmacovigilance Services and Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Pharmacovigilance Services and Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Pharmacovigilance Services and Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 45. Eurofins Scientific Company Information
Table 46. Eurofins Scientific Business Overview
Table 47. Eurofins Scientific Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 48. Eurofins Scientific Pharmacovigilance Services and Solutions Product Portfolio
Table 49. Eurofins Scientific Recent Developments
Table 50. Accenture Company Information
Table 51. Accenture Business Overview
Table 52. Accenture Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 53. Accenture Pharmacovigilance Services and Solutions Product Portfolio
Table 54. Accenture Recent Developments
Table 55. PPD Company Information
Table 56. PPD Business Overview
Table 57. PPD Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 58. PPD Pharmacovigilance Services and Solutions Product Portfolio
Table 59. PPD Recent Developments
Table 60. SGS Company Information
Table 61. SGS Business Overview
Table 62. SGS Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 63. SGS Pharmacovigilance Services and Solutions Product Portfolio
Table 64. SGS Recent Developments
Table 65. WuXi AppTec Company Information
Table 66. WuXi AppTec Business Overview
Table 67. WuXi AppTec Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 68. WuXi AppTec Pharmacovigilance Services and Solutions Product Portfolio
Table 69. WuXi AppTec Recent Developments
Table 70. Cognizant Company Information
Table 71. Cognizant Business Overview
Table 72. Cognizant Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 73. Cognizant Pharmacovigilance Services and Solutions Product Portfolio
Table 74. Cognizant Recent Developments
Table 75. ICON Company Information
Table 76. ICON Business Overview
Table 77. ICON Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 78. ICON Pharmacovigilance Services and Solutions Product Portfolio
Table 79. ICON Recent Developments
Table 80. IQVIA Company Information
Table 81. IQVIA Business Overview
Table 82. IQVIA Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 83. IQVIA Pharmacovigilance Services and Solutions Product Portfolio
Table 84. IQVIA Recent Developments
Table 85. Parexel Company Information
Table 86. Parexel Business Overview
Table 87. Parexel Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 88. Parexel Pharmacovigilance Services and Solutions Product Portfolio
Table 89. Parexel Recent Developments
Table 90. United BioSource Company Information
Table 91. United BioSource Business Overview
Table 92. United BioSource Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 93. United BioSource Pharmacovigilance Services and Solutions Product Portfolio
Table 94. United BioSource Recent Developments
Table 95. Vial Company Information
Table 96. Vial Business Overview
Table 97. Vial Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 98. Vial Pharmacovigilance Services and Solutions Product Portfolio
Table 99. Vial Recent Developments
Table 100. Wipro Company Information
Table 101. Wipro Business Overview
Table 102. Wipro Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 103. Wipro Pharmacovigilance Services and Solutions Product Portfolio
Table 104. Wipro Recent Developments
Table 105. PrimeVigilance Company Information
Table 106. PrimeVigilance Business Overview
Table 107. PrimeVigilance Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 108. PrimeVigilance Pharmacovigilance Services and Solutions Product Portfolio
Table 109. PrimeVigilance Recent Developments
Table 110. Aixial Group Company Information
Table 111. Aixial Group Business Overview
Table 112. Aixial Group Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 113. Aixial Group Pharmacovigilance Services and Solutions Product Portfolio
Table 114. Aixial Group Recent Developments
Table 115. TransPerfect Company Information
Table 116. TransPerfect Business Overview
Table 117. TransPerfect Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 118. TransPerfect Pharmacovigilance Services and Solutions Product Portfolio
Table 119. TransPerfect Recent Developments
Table 120. ProPharma Company Information
Table 121. ProPharma Business Overview
Table 122. ProPharma Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 123. ProPharma Pharmacovigilance Services and Solutions Product Portfolio
Table 124. ProPharma Recent Developments
Table 125. HCLTech Company Information
Table 126. HCLTech Business Overview
Table 127. HCLTech Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 128. HCLTech Pharmacovigilance Services and Solutions Product Portfolio
Table 129. HCLTech Recent Developments
Table 130. QbD Group Company Information
Table 131. QbD Group Business Overview
Table 132. QbD Group Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 133. QbD Group Pharmacovigilance Services and Solutions Product Portfolio
Table 134. QbD Group Recent Developments
Table 135. Quanticate Company Information
Table 136. Quanticate Business Overview
Table 137. Quanticate Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 138. Quanticate Pharmacovigilance Services and Solutions Product Portfolio
Table 139. Quanticate Recent Developments
Table 140. Qinecsa Solutions Company Information
Table 141. Qinecsa Solutions Business Overview
Table 142. Qinecsa Solutions Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 143. Qinecsa Solutions Pharmacovigilance Services and Solutions Product Portfolio
Table 144. Qinecsa Solutions Recent Developments
Table 145. Veristat Company Information
Table 146. Veristat Business Overview
Table 147. Veristat Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 148. Veristat Pharmacovigilance Services and Solutions Product Portfolio
Table 149. Veristat Recent Developments
Table 150. Veeda Company Information
Table 151. Veeda Business Overview
Table 152. Veeda Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 153. Veeda Pharmacovigilance Services and Solutions Product Portfolio
Table 154. Veeda Recent Developments
Table 155. Tigermed Company Information
Table 156. Tigermed Business Overview
Table 157. Tigermed Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 158. Tigermed Pharmacovigilance Services and Solutions Product Portfolio
Table 159. Tigermed Recent Developments
Table 160. Clarivate Company Information
Table 161. Clarivate Business Overview
Table 162. Clarivate Revenue in Pharmacovigilance Services and Solutions Business (2021-2026) & (US$ Million)
Table 163. Clarivate Pharmacovigilance Services and Solutions Product Portfolio
Table 164. Clarivate Recent Developments
Table 165. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pharmacovigilance Services and Solutions Product Image
Figure 5. Global Pharmacovigilance Services and Solutions Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Pharmacovigilance Services and Solutions Market Share by Type: 2025 VS 2032
Figure 7. Writing and Submitting Documents and Reports Product
Figure 8. Security Database System Services and Data Management Product
Figure 9. Signal Detection and Evaluation Product
Figure 10. Training and Consulting Product
Figure 11. Other Product
Figure 12. Global Pharmacovigilance Services and Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Pharmacovigilance Services and Solutions Market Share by Application: 2025 VS 2032
Figure 14. Preclinical Product
Figure 15. Clinical Phase Product
Figure 16. Post-launch Product
Figure 17. Global Pharmacovigilance Services and Solutions Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Pharmacovigilance Services and Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Pharmacovigilance Services and Solutions Market Share by Region: 2025 VS 2032
Figure 20. Global Pharmacovigilance Services and Solutions Market Share by Players in 2025
Figure 21. Global Pharmacovigilance Services and Solutions Manufacturers Established Date
Figure 22. Global Top 5 and 10 Pharmacovigilance Services and Solutions Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 26. United States Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 29. Europe Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 31. Germany Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 41. China Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 46. Australia Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 51. Brazil Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Pharmacovigilance Services and Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Eurofins Scientific Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 57. Accenture Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 58. PPD Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 59. SGS Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 60. WuXi AppTec Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 61. Cognizant Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 62. ICON Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 63. IQVIA Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 64. Parexel Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 65. United BioSource Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 66. Vial Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 67. Wipro Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 68. PrimeVigilance Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 69. Aixial Group Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 70. TransPerfect Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 71. ProPharma Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 72. HCLTech Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 73. QbD Group Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 74. Quanticate Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 75. Qinecsa Solutions Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 76. Veristat Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 77. Veeda Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 78. Tigermed Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Figure 79. Clarivate Revenue Growth Rate in Pharmacovigilance Services and Solutions Business (2021-2026)
Scope & coverage.
Types
- Writing and Submitting Documents and Reports
- Security Database System Services and Data Management
- Signal Detection and Evaluation
- Training and Consulting
- Other
Applications
- Preclinical
- Clinical Phase
- Post-launch
Companies covered
- Eurofins Scientific
- Accenture
- PPD
- SGS
- WuXi AppTec
- Cognizant
- ICON
- IQVIA
- Parexel
- United BioSource
- Vial
- Wipro
- PrimeVigilance
- Aixial Group
- TransPerfect
- ProPharma
- HCLTech
- QbD Group
- Quanticate
- Qinecsa Solutions
- Veristat
- Veeda
- Tigermed
- Clarivate
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmacovigilance Services and Solutions by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Writing and Submitting Documents and Reports
- 2.2.3 Security Database System Services and Data Management
- 2.2.4 Signal Detection and Evaluation
- 2.2.5 Training and Consulting
- 2.2.6 Other
- 2.3 Pharmacovigilance Services and Solutions by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Preclinical
- 2.3.3 Clinical Phase
- 2.3.4 Post-launch
- 2.4 Assumptions and Limitations
3 Pharmacovigilance Services and Solutions Breakdown Data by Type
- 3.1 Global Pharmacovigilance Services and Solutions Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmacovigilance Services and Solutions Forecasted Market Size by Type (2027-2032)
4 Pharmacovigilance Services and Solutions Breakdown Data by Application
- 4.1 Global Pharmacovigilance Services and Solutions Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmacovigilance Services and Solutions Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmacovigilance Services and Solutions Market Perspective (2021-2032)
- 5.2 Global Pharmacovigilance Services and Solutions Growth Trends by Region
- 5.2.1 Global Pharmacovigilance Services and Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmacovigilance Services and Solutions Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmacovigilance Services and Solutions Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmacovigilance Services and Solutions Market Dynamics
- 5.3.1 Pharmacovigilance Services and Solutions Industry Trends
- 5.3.2 Pharmacovigilance Services and Solutions Market Drivers
- 5.3.3 Pharmacovigilance Services and Solutions Market Challenges
- 5.3.4 Pharmacovigilance Services and Solutions Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmacovigilance Services and Solutions Players by Revenue
- 6.1.1 Global Top Pharmacovigilance Services and Solutions Players by Revenue (2021-2026)
- 6.1.2 Global Pharmacovigilance Services and Solutions Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmacovigilance Services and Solutions Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmacovigilance Services and Solutions Head Office and Area Served
- 6.4 Global Pharmacovigilance Services and Solutions Players, Product Type & Application
- 6.5 Global Pharmacovigilance Services and Solutions Manufacturers Established Date
- 6.6 Global Pharmacovigilance Services and Solutions Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 7.2 North America Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 7.4 North America Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 8.2 Europe Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 8.4 Europe Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 10.2 South America Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 10.4 South America Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmacovigilance Services and Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.1.4 Eurofins Scientific Pharmacovigilance Services and Solutions Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Accenture
- 12.2.1 Accenture Company Information
- 12.2.2 Accenture Business Overview
- 12.2.3 Accenture Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.2.4 Accenture Pharmacovigilance Services and Solutions Product Portfolio
- 12.2.5 Accenture Recent Developments
- 12.3 PPD
- 12.3.1 PPD Company Information
- 12.3.2 PPD Business Overview
- 12.3.3 PPD Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.3.4 PPD Pharmacovigilance Services and Solutions Product Portfolio
- 12.3.5 PPD Recent Developments
- 12.4 SGS
- 12.4.1 SGS Company Information
- 12.4.2 SGS Business Overview
- 12.4.3 SGS Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.4.4 SGS Pharmacovigilance Services and Solutions Product Portfolio
- 12.4.5 SGS Recent Developments
- 12.5 WuXi AppTec
- 12.5.1 WuXi AppTec Company Information
- 12.5.2 WuXi AppTec Business Overview
- 12.5.3 WuXi AppTec Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.5.4 WuXi AppTec Pharmacovigilance Services and Solutions Product Portfolio
- 12.5.5 WuXi AppTec Recent Developments
- 12.6 Cognizant
- 12.6.1 Cognizant Company Information
- 12.6.2 Cognizant Business Overview
- 12.6.3 Cognizant Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.6.4 Cognizant Pharmacovigilance Services and Solutions Product Portfolio
- 12.6.5 Cognizant Recent Developments
- 12.7 ICON
- 12.7.1 ICON Company Information
- 12.7.2 ICON Business Overview
- 12.7.3 ICON Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.7.4 ICON Pharmacovigilance Services and Solutions Product Portfolio
- 12.7.5 ICON Recent Developments
- 12.8 IQVIA
- 12.8.1 IQVIA Company Information
- 12.8.2 IQVIA Business Overview
- 12.8.3 IQVIA Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.8.4 IQVIA Pharmacovigilance Services and Solutions Product Portfolio
- 12.8.5 IQVIA Recent Developments
- 12.9 Parexel
- 12.9.1 Parexel Company Information
- 12.9.2 Parexel Business Overview
- 12.9.3 Parexel Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.9.4 Parexel Pharmacovigilance Services and Solutions Product Portfolio
- 12.9.5 Parexel Recent Developments
- 12.10 United BioSource
- 12.10.1 United BioSource Company Information
- 12.10.2 United BioSource Business Overview
- 12.10.3 United BioSource Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.10.4 United BioSource Pharmacovigilance Services and Solutions Product Portfolio
- 12.10.5 United BioSource Recent Developments
- 12.11 Vial
- 12.11.1 Vial Company Information
- 12.11.2 Vial Business Overview
- 12.11.3 Vial Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.11.4 Vial Pharmacovigilance Services and Solutions Product Portfolio
- 12.11.5 Vial Recent Developments
- 12.12 Wipro
- 12.12.1 Wipro Company Information
- 12.12.2 Wipro Business Overview
- 12.12.3 Wipro Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.12.4 Wipro Pharmacovigilance Services and Solutions Product Portfolio
- 12.12.5 Wipro Recent Developments
- 12.13 PrimeVigilance
- 12.13.1 PrimeVigilance Company Information
- 12.13.2 PrimeVigilance Business Overview
- 12.13.3 PrimeVigilance Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.13.4 PrimeVigilance Pharmacovigilance Services and Solutions Product Portfolio
- 12.13.5 PrimeVigilance Recent Developments
- 12.14 Aixial Group
- 12.14.1 Aixial Group Company Information
- 12.14.2 Aixial Group Business Overview
- 12.14.3 Aixial Group Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.14.4 Aixial Group Pharmacovigilance Services and Solutions Product Portfolio
- 12.14.5 Aixial Group Recent Developments
- 12.15 TransPerfect
- 12.15.1 TransPerfect Company Information
- 12.15.2 TransPerfect Business Overview
- 12.15.3 TransPerfect Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.15.4 TransPerfect Pharmacovigilance Services and Solutions Product Portfolio
- 12.15.5 TransPerfect Recent Developments
- 12.16 ProPharma
- 12.16.1 ProPharma Company Information
- 12.16.2 ProPharma Business Overview
- 12.16.3 ProPharma Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.16.4 ProPharma Pharmacovigilance Services and Solutions Product Portfolio
- 12.16.5 ProPharma Recent Developments
- 12.17 HCLTech
- 12.17.1 HCLTech Company Information
- 12.17.2 HCLTech Business Overview
- 12.17.3 HCLTech Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.17.4 HCLTech Pharmacovigilance Services and Solutions Product Portfolio
- 12.17.5 HCLTech Recent Developments
- 12.18 QbD Group
- 12.18.1 QbD Group Company Information
- 12.18.2 QbD Group Business Overview
- 12.18.3 QbD Group Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.18.4 QbD Group Pharmacovigilance Services and Solutions Product Portfolio
- 12.18.5 QbD Group Recent Developments
- 12.19 Quanticate
- 12.19.1 Quanticate Company Information
- 12.19.2 Quanticate Business Overview
- 12.19.3 Quanticate Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.19.4 Quanticate Pharmacovigilance Services and Solutions Product Portfolio
- 12.19.5 Quanticate Recent Developments
- 12.20 Qinecsa Solutions
- 12.20.1 Qinecsa Solutions Company Information
- 12.20.2 Qinecsa Solutions Business Overview
- 12.20.3 Qinecsa Solutions Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.20.4 Qinecsa Solutions Pharmacovigilance Services and Solutions Product Portfolio
- 12.20.5 Qinecsa Solutions Recent Developments
- 12.21 Veristat
- 12.21.1 Veristat Company Information
- 12.21.2 Veristat Business Overview
- 12.21.3 Veristat Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.21.4 Veristat Pharmacovigilance Services and Solutions Product Portfolio
- 12.21.5 Veristat Recent Developments
- 12.22 Veeda
- 12.22.1 Veeda Company Information
- 12.22.2 Veeda Business Overview
- 12.22.3 Veeda Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.22.4 Veeda Pharmacovigilance Services and Solutions Product Portfolio
- 12.22.5 Veeda Recent Developments
- 12.23 Tigermed
- 12.23.1 Tigermed Company Information
- 12.23.2 Tigermed Business Overview
- 12.23.3 Tigermed Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.23.4 Tigermed Pharmacovigilance Services and Solutions Product Portfolio
- 12.23.5 Tigermed Recent Developments
- 12.24 Clarivate
- 12.24.1 Clarivate Company Information
- 12.24.2 Clarivate Business Overview
- 12.24.3 Clarivate Revenue in Pharmacovigilance Services and Solutions Business (2021-2026)
- 12.24.4 Clarivate Pharmacovigilance Services and Solutions Product Portfolio
- 12.24.5 Clarivate Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst